Latest Diabetes: Type II news
ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic, Bariatric Surgery
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Continuous Glucose Monitors Not Accurate in People Without Diabetes
posted October 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers
posted October 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Related Articles
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy 
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
